| Year |
Citation |
Score |
| 2016 |
Bailey SD, Desai K, Kron KJ, Mazrooei P, Sinnott-Armstrong NA, Treloar AE, Dowar M, Thu KL, Cescon DW, Silvester J, Yang SY, Wu X, Pezo RC, Haibe-Kains B, Mak TW, et al. Noncoding somatic and inherited single-nucleotide variants converge to promote ESR1 expression in breast cancer. Nature Genetics. PMID 27571262 DOI: 10.1038/Ng.3650 |
0.303 |
|
| 2010 |
Wang D, Pezo RC, Corner G, Sison C, Lesser ML, Shenoy SM, Mariadason JM, Singer RH, Augenlicht LH. Altered dynamics of intestinal cell maturation in Apc1638N/+ mice. Cancer Research. 70: 5348-57. PMID 20570902 DOI: 10.1158/0008-5472.Can-09-4593 |
0.567 |
|
| 2008 |
Pezo RC, Gandhi SJ, Shirley LA, Pestell RG, Augenlicht LH, Singer RH. Single-cell transcription site activation predicts chemotherapy response in human colorectal tumors. Cancer Research. 68: 4977-82. PMID 18593893 DOI: 10.1158/0008-5472.Can-07-6770 |
0.586 |
|
| 2008 |
Pezo RC, Singer RH. Nuclear microenvironment in cancer diagnosis and treatment. Journal of Cellular Biochemistry. 104: 1953-63. PMID 17477352 DOI: 10.1002/Jcb.21353 |
0.523 |
|
| 2002 |
Wilson AJ, Velcich A, Arango D, Kurland AR, Shenoy SM, Pezo RC, Levsky JM, Singer RH, Augenlicht LH. Novel detection and differential utilization of a c-myc transcriptional block in colon cancer chemoprevention. Cancer Research. 62: 6006-10. PMID 12414619 |
0.565 |
|
| 2002 |
Levsky JM, Shenoy SM, Pezo RC, Singer RH. Single-cell gene expression profiling. Science (New York, N.Y.). 297: 836-40. PMID 12161654 DOI: 10.1126/Science.1072241 |
0.564 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2021 |
Feng Y, Li C, Stewart JA, Barbulescu P, Desivo NS, Álvarez-Quilón A, Pezo RC, Perera MLW, Chan K, Tong AHY, Mohamad-Ramshan R, Berru M, Nakib D, Li G, Kardar GA, et al. FAM72A antagonizes UNG2 to promote mutagenic repair during antibody maturation. Nature. PMID 34819670 DOI: 10.1038/s41586-021-04144-4 |
0.237 |
|
| 2014 |
Belcheva A, Irrazabal T, Robertson SJ, Streutker C, Maughan H, Rubino S, Moriyama EH, Copeland JK, Kumar S, Green B, Geddes K, Pezo RC, Navarre WW, Milosevic M, Wilson BC, et al. Gut microbial metabolism drives transformation of MSH2-deficient colon epithelial cells. Cell. 158: 288-99. PMID 25036629 DOI: 10.1016/J.Cell.2014.04.051 |
0.222 |
|
| 2017 |
Pezo RC, Chen TW, Berman HK, Mulligan AM, Razak AA, Siu LL, Cescon DW, Amir E, Elser C, Warr DG, Sridhar SS, Yu C, Wang L, Stockley TL, Kamel-Reid S, et al. Impact of multi-gene mutational profiling on clinical trial outcomes in metastatic breast cancer. Breast Cancer Research and Treatment. PMID 29177603 DOI: 10.1007/S10549-017-4580-2 |
0.178 |
|
| 2021 |
Andrews MC, Duong CPM, Gopalakrishnan V, Iebba V, Chen WS, Derosa L, Khan MAW, Cogdill AP, White MG, Wong MC, Ferrere G, Fluckiger A, Roberti MP, Opolon P, Alou MT, ... ... Pezo RC, et al. Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade. Nature Medicine. PMID 34239137 DOI: 10.1038/s41591-021-01406-6 |
0.17 |
|
| 2021 |
Angrish MD, Agha A, Pezo RC. Association of Antibiotics and Other Drugs with Clinical Outcomes in Metastatic Melanoma Patients Treated with Immunotherapy. Journal of Skin Cancer. 2021: 9120162. PMID 34336290 DOI: 10.1155/2021/9120162 |
0.157 |
|
| 2021 |
Shirdarreh M, Aziza O, Pezo RC, Jerzak KJ, Warner E. Patients' and Oncologists' Knowledge and Expectations Regarding Tumor Multigene Next-Generation Sequencing: A Narrative Review. The Oncologist. PMID 33823080 DOI: 10.1002/onco.13783 |
0.155 |
|
| 2022 |
Blanchette P, Sivajohanathan D, Bartlett J, Eisen A, Feilotter H, Pezo R, Turashvili G, Williams P. Clinical Utility of Multigene Profiling Assays in Early-Stage Invasive Breast Cancer: An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline. Current Oncology (Toronto, Ont.). 29: 2599-2615. PMID 35448187 DOI: 10.3390/curroncol29040213 |
0.136 |
|
| 2019 |
Pezo RC, Wong M, Martin A. Impact of the gut microbiota on immune checkpoint inhibitor-associated toxicities. Therapeutic Advances in Gastroenterology. 12: 1756284819870911. PMID 31555343 DOI: 10.1177/1756284819870911 |
0.114 |
|
| 2023 |
Thavendiranathan P, Houbois C, Marwick TH, Kei T, Saha S, Runeckles K, Huang F, Shalmon T, Thorpe KE, Pezo RC, Prica A, Maze D, Abdel-Qadir H, Connelly K, Chan J, et al. Statins to prevent early cardiac dysfunction in cancer patients at increased cardiotoxicity risk receiving anthracyclines. European Heart Journal. Cardiovascular Pharmacotherapy. PMID 37120736 DOI: 10.1093/ehjcvp/pvad031 |
0.106 |
|
| 2022 |
Tonneau M, Nolin-Lapalme A, Kazandjian S, Auclin E, Panasci J, Benlaifaoui M, Ponce M, Al-Saleh A, Belkaid W, Naimi S, Mihalcioiu C, Watson I, Bouin M, Miller W, Hudson M, ... ... Pezo RC, et al. serology is associated with worse overall survival in patients with melanoma treated with immune checkpoint inhibitors. Oncoimmunology. 11: 2096535. PMID 35832043 DOI: 10.1080/2162402X.2022.2096535 |
0.098 |
|
| 2023 |
Jackson EB, Curry L, Mariano C, Hsu T, Cook S, Pezo RC, Savard MF, Desautels DN, Leblanc D, Gelmon KA. Key Considerations for the Treatment of Advanced Breast Cancer in Older Adults: An Expert Consensus of the Canadian Treatment Landscape. Current Oncology (Toronto, Ont.). 31: 145-167. PMID 38248095 DOI: 10.3390/curroncol31010010 |
0.093 |
|
| 2022 |
Pezo RC, Chan KKW, Mata DGMM, Menjak I, Eisen A, Trudeau M. Impact of body mass index on survival in women receiving chemotherapy for early breast cancer. Breast Cancer Research and Treatment. PMID 36114940 DOI: 10.1007/s10549-022-06744-8 |
0.087 |
|
| 2021 |
Shirdarreh M, Pezo RC. Impact of obesity on clinical outcomes in hormone receptor-positive breast cancer: a systematic review. Breast Cancer (Tokyo, Japan). PMID 33428124 DOI: 10.1007/s12282-020-01213-w |
0.085 |
|
| 2021 |
Naderi-Azad S, Sickandar F, Pezo RC. Cutaneous immune-related adverse events in patients with metastatic melanoma on antiprogrammed cell death protein 1 and anticytotoxic T-lymphocyte-associated protein 4 therapy: A retrospective cohort study. Jaad International. 2: 19-21. PMID 34409348 DOI: 10.1016/j.jdin.2020.10.005 |
0.08 |
|
| 2020 |
Komorowski AS, MacKay HJ, Pezo RC. Quality of adverse event reporting in phase III randomized controlled trials of breast and colorectal cancer: A systematic review. Cancer Medicine. PMID 32452660 DOI: 10.1002/cam4.3095 |
0.075 |
|
| 2019 |
Pezo RC, Yan AT, Earle C, Chan KK. Underuse of ECG monitoring in oncology patients receiving QT-interval prolonging drugs. Heart (British Cardiac Society). PMID 31129611 DOI: 10.1136/heartjnl-2018-314674 |
0.058 |
|
| 2021 |
Meng Y, Reilly RM, Pezo RC, Trudeau M, Sahgal A, Singnurkar A, Perry J, Myrehaug S, Pople CB, Davidson B, Llinas M, Hyen C, Huang Y, Hamani C, Suppiah S, et al. MR-guided focused ultrasound enhances delivery of trastuzumab to Her2-positive brain metastases. Science Translational Medicine. 13: eabj4011. PMID 34644145 DOI: 10.1126/scitranslmed.abj4011 |
0.028 |
|
| Hide low-probability matches. |